menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Implications of the ACCORD, ADVANCE and VA Diabetes Trials

close
Implications of the ACCORD, ADVANCE and VA Diabetes Trials
Restart
Resume
Read full article
Choose a format
Media formats available:
A pre-test is required to view this content.
A pre-survey is required to view this content.
Details
Presenters
Comments
  • Overview

    The ACCORD, ADVANCE and VA Diabetes Trials seem to indicate that there is no real benefit of intensive glycemic control on cardiovascular events in patients with type 2 diabetes. Join host Dr. Steven Edelman and his guest, executive director of the International Diabetes Center at Park Nicollet, Dr. Richard Bergenstal, as they discuss the implications on clinical care and benefits of glycemic control.

Facebook Comments

Recommended
Details
Presenters
Comments
  • Overview

    The ACCORD, ADVANCE and VA Diabetes Trials seem to indicate that there is no real benefit of intensive glycemic control on cardiovascular events in patients with type 2 diabetes. Join host Dr. Steven Edelman and his guest, executive director of the International Diabetes Center at Park Nicollet, Dr. Richard Bergenstal, as they discuss the implications on clinical care and benefits of glycemic control.

Facebook Comments

Programs 5/18/21